Tasigna (nilotinib), among the most well known growth tranquilizes in the world, has been found to cause fast, extreme and irreversible atherosclerosis, a condition which can bring about appendage removal, fringe blood vessel malady and cardiovascular issues, and passing. Used to treat Philadelphia chromosome-positive ceaseless myeloid leukemia, Tasigna was connected to atherosclerosis in 2011, yet the American open was not cautioned of the hazard. Through no blame of their own, several thousands have taken Tasigna, in trusts it would enhance their wellbeing and totally ignorant of the threat of Tasigna atherosclerosis.